These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 25653131

  • 1. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M, Zakeri S, Pirahmadi S, Raeisi A, Djadid ND.
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [Abstract] [Full Text] [Related]

  • 2. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND.
    Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
    [Abstract] [Full Text] [Related]

  • 3. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA, Mahdy MA, Lim YA.
    Malar J; 2015 Dec 22; 14():516. PubMed ID: 26693691
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F, Bakoua D, Fesser A, Nkombo M, Vouvoungui C, Ntoumi F.
    Infect Genet Evol; 2015 Jul 22; 33():32-6. PubMed ID: 25934142
    [Abstract] [Full Text] [Related]

  • 5. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP, Gomes LR, Gama BE, Almeida-de-Oliveira NK, Fortes F, Ménard D, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F.
    Malar J; 2016 Jun 07; 15():309. PubMed ID: 27267365
    [Abstract] [Full Text] [Related]

  • 6. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM, Al-Mekhlafi HM, Atroosh WM, Ghzwani AH, Zain KA, Abdulhaq AA, Ghailan KY, Anwar AA, Eisa ZM.
    Malar J; 2020 Dec 02; 19(1):446. PubMed ID: 33267841
    [Abstract] [Full Text] [Related]

  • 7. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N.
    Acta Trop; 2016 Dec 02; 164():329-336. PubMed ID: 27647575
    [Abstract] [Full Text] [Related]

  • 8. Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
    Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND.
    Infect Genet Evol; 2012 Jan 02; 12(1):38-44. PubMed ID: 22020253
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B.
    Acta Trop; 2013 Dec 02; 128(3):636-41. PubMed ID: 24055717
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.
    Malar J; 2018 Dec 17; 17(1):471. PubMed ID: 30558587
    [Abstract] [Full Text] [Related]

  • 11. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM, Al-Mekhlafi HM, Snounou G, Al-Jasari A, Sady H, Nasr NA, Lau YL, Surin J.
    Malar J; 2016 May 27; 15(1):295. PubMed ID: 27234587
    [Abstract] [Full Text] [Related]

  • 12. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T, Chen J, Fu H, Wu K, Yao Y, Eyi JUM, Matesa RA, Obono MMO, Du W, Tan H, Lin M, Li J.
    Malar J; 2019 Mar 26; 18(1):101. PubMed ID: 30914041
    [Abstract] [Full Text] [Related]

  • 13. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
    Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A.
    Malar J; 2017 Jan 13; 16(1):28. PubMed ID: 28086777
    [Abstract] [Full Text] [Related]

  • 14. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
    Ruh E, Bateko JP, Imir T, Taylan-Ozkan A.
    Malar J; 2018 Jan 09; 17(1):17. PubMed ID: 29316929
    [Abstract] [Full Text] [Related]

  • 15. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA.
    Infect Genet Evol; 2009 Sep 09; 9(5):778-83. PubMed ID: 19379843
    [Abstract] [Full Text] [Related]

  • 16. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
    Fernandes N, Figueiredo P, do Rosário VE, Cravo P.
    Malar J; 2007 Mar 23; 6():35. PubMed ID: 17378942
    [Abstract] [Full Text] [Related]

  • 17. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S, Bharti PK, Shukla MM, Ali NA, Kashyotia SS, Kumar A, Dhariwal AC, Singh N.
    Pathog Glob Health; 2017 Jun 23; 111(4):186-194. PubMed ID: 28549390
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
    Zakeri S, Farahani MS, Afsharpad M, Salehi M, Raeisi A, Djadid ND.
    Int J Infect Dis; 2010 Sep 23; 14 Suppl 3():e123-8. PubMed ID: 20399698
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P, Menard S, Iriart X, Nsango SE, Tchioffo MT, Abate L, Awono-Ambéné PH, Morlais I, Berry A.
    J Antimicrob Chemother; 2015 Sep 23; 70(9):2566-71. PubMed ID: 26080363
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
    Am J Trop Med Hyg; 2004 Dec 23; 71(6):696-702. PubMed ID: 15642957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.